Showing results (131-140 of 160) with videos related to
Sort By:
Pageof 16
Lancet (London, England)|October 28, 2023
Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trialJuan F Iglesias, Marco Roffi, Sylvain Losdat, et al.Circulation|July 22, 2009
Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosisStéphane Cook, Elena Ladich, Gaku Nakazawa, et al.European Heart Journal|February 15, 2008
Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patientsMichael Billinger, Jonas Beutler, Keywan R Taghetchian, et al.Journal of the American Heart Association|November 8, 2019
Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting StentsJuan F Iglesias, Dik Heg, Marco Roffi, et al.Circulation|June 8, 2011
Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trialLorenz Räber, Lea Wohlwend, Mathias Wigger, et al.European Heart Journal|April 22, 2017
Late thrombotic events after bioresorbable scaffold implantation: a systematic review and meta-analysis of randomized clinical trialsCarlos Collet, Taku Asano, Yosuke Miyazaki, et al.Journal of the American Heart Association|March 17, 2016
Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE TrialRainer Zbinden, Raffaele Piccolo, Dik Heg, et al.Chronobiology International|October 25, 2013
Relationship between time of day and periprocedural myocardial infarction after elective angioplastyStephane Fournier, Serban Puricel, Beata Morawiec, et al.JACC. Cardiovascular Interventions|June 25, 2011
Comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularization a randomized controlled trialThomas Pilgrim, Lorenz Räber, Andreas Limacher, et al.Lancet (London, England)|September 2, 2018
Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trialThomas Pilgrim, Raffaele Piccolo, Dik Heg, et al.Pageof 16